Cayenne

Capsicum belongs to the nightshade family (Solanaceae), along with tomato, potato, and tobacco. Plants are typically annuals in temperate gardens and short-lived perennials in frost-free climates. They are branching herbs or small shrubs with simple ovate leaves and pendant or erect berries that botanists still call fruits. The “pepper” of commerce is the hollow pericarp; the hottest tissue is the pale placenta that holds the seeds, not the seeds themselves.

Cayenne as a spice usually means long, slender, tapering pods of C. annuum, dried and ground to a brick-red powder. Heat is scored in Scoville units, which estimate capsaicinoid concentration. Culinary cayenne is often in the tens of thousands of Scoville units—hot, but far below habanero or pure capsaicin. Color comes from carotenoids; pungency is a separate chemistry.

The European herbal drug Capsici fructus is defined more tightly than grocery cayenne: Capsicum annuum var. minimum and small-fruited varieties of C. frutescens. Labels that say “cayenne,” “capsicum,” “chili,” or “African bird pepper” can therefore refer to overlapping but not identical material. Substitutions with milder paprika (also C. annuum, low capsaicin) change the pharmacology entirely.

The medicinal part is the dried ripe fruit. Leaves and roots are not the traditional drug. Fresh pods are food. Isolated capsaicin used in creams and patches is a single molecule purified or synthesized from this chemistry—not a whole-fruit powder.

Chili peppers were domesticated in the Americas. Starch grains from chilies have been recovered at seven archaeological sites from the Bahamas to southern Peru, the oldest about 6,000 years old, often alongside maize (Perry and colleagues, Science 2007). For Capsicum annuum, the species behind most cayenne, a 2014 study combining genetic, archaeological, ecological, and linguistic evidence points to Mexico, most likely central-east Mexico near the Tehuacán Valley (Kraft and colleagues, PNAS). Chili served as food, as a pungent medicine, and as a ritual and trade good. Spanish and Portuguese ships carried the plant worldwide in the sixteenth century. Within a few generations it had entered Indian, West African, Chinese, and Hungarian cooking so thoroughly that later writers sometimes forgot it was New World.

European herbalists absorbed chili as a “heating” spice in humoral terms: a stimulant to move stagnant cold, a counterirritant on the skin, a digestive bitter-pungent. In nineteenth-century North America, Thomsonian and Physiomedical physicians made cayenne a signature internal stimulant—“the purest stimulant in nature”—used for fevers, collapse, and “cold” states. That tradition explains why American herbalism still talks about cayenne as a first-aid heat rather than only a kitchen pepper. It does not make those internal uses equivalent to modern trial evidence.

Capsaicin was isolated in the early nineteenth century (Christian Friedrich Bucholz, 1816) and its structure worked out in the early twentieth. The receptor story is much later. In 1997, David Julius’s group cloned TRPV1, the ion channel that capsaicin opens on pain-sensing neurons—the same channel that also responds to noxious heat. That finding turned a folk counterirritant into a named molecular tool and, eventually, into licensed high-concentration patches.

Today cayenne sits in three markets at once: spice aisle, dietary supplement, and dermatology. Keeping those markets separate matters: a cream that helps a knee is not a reason to swallow megadose capsules, and a prescription patch for shingles pain is not a reason to put kitchen powder on the skin.

Capsaicin is a selective agonist of TRPV1 (transient receptor potential vanilloid 1), a calcium-permeable channel on nociceptors. Binding feels like burn because the neuron is reporting heat and chemical irritation. With repeated or high exposure, those terminals can desensitize: they stop firing as readily, and at high concentrations the terminals can defunctionalize for weeks as the axon tip is damaged and later regenerates. That is the paradox of “fighting fire with fire.” Low-dose creams mainly irritate and then modestly quiet the same fibers; high-dose (8%) medical patches are a controlled ablation of epidermal nociceptor endings, not a spice rub.

Substance P depletion is the older textbook line. It is part of the story, not the whole mechanism. Calcium overload, mitochondrial stress in the terminal, and delayed regeneration better explain why a single high-dose application can last months—and why the first application hurts.

Swallowed cayenne stimulates TRPV1 in the mouth and gut: salivation, gastric blood flow, a sense of warmth, sometimes cramping or reflux. Claims that this speeds metabolism enough to treat obesity overstate a small thermogenic effect. Capsaicin is not a systemic NSAID and is not an opioid. Whole fruit also contains carotenoids, vitamin C (in the fresh pod), and flavonoids; those do not make a capsule a multivitamin or an anti-inflammatory drug.

The use with the strongest clinical footing is topical. EMA’s herbal monograph on Capsici fructus supports well-established use of standardized capsicum extracts in cutaneous preparations for muscle pain, such as low-back pain, in adults. NCCIH similarly notes that topical cayenne (creams, plasters) can reduce low-back pain, citing herbal-medicine reviews. Cochrane-linked work on herbal treatments for low-back pain found Capsicum preparations reduced pain more than placebo, with evidence quality no better than moderate.

Over-the-counter capsaicin creams (often 0.025% to 0.075%) are used for minor arthritic and musculoskeletal aches. Guideline language for osteoarthritis is cautious: topical capsaicin is sometimes conditionally recommended for knee OA and not a first-line plan for every joint. High-concentration (8%) capsaicin patches are prescription products studied for postherpetic neuralgia and some peripheral neuropathic pain; a Cochrane review of high-concentration topical capsaicin found modest benefit in selected neuropathic conditions, with burning as the expected local cost. Those patches are not DIY cayenne.

Traditional internal uses—poor circulation, “sluggish” digestion, feverish colds, as a stimulant in collapse—have a long history but have not been well tested as capsules. Culinary amounts in food are a different exposure from gram-dose supplements. Weight-loss and “heart cleanse” claims for whole-fruit cayenne are not supported by current research. Capsaicin research in metabolism is interesting, and more research would help; it is not a reason to take large amounts of tincture.

Cayenne powder in the eyes or airways causes injury and has no therapeutic role. Do not use pepper this way on yourself or anyone else.

Food use is the baseline: dried pods, flakes, and powder in cooking. Heat is unpredictable between brands. Wash hands after handling; oils transfer easily to eyes and genitals.

Herbal products include encapsulated powder, liquid extracts, and topical plasters or creams standardized to capsaicinoids. European cutaneous medicines use soft extracts with defined capsaicinoid ranges—not kitchen cayenne taped to the lower back. Follow labeled contact time; do not occlude kitchen powder under plastic.

OTC capsaicin creams are applied thinly to intact skin, often several times daily, and require days of use before anyone can judge them. The first applications burn. High-strength 8% patches are applied in clinic, sometimes with local anesthetic, for a timed period, then removed. They are drugs, not spices.

There is no single “cayenne dose” that maps from soup to patch. If someone and their clinician choose a topical product, a labeled capsaicin percentage is more rational than a homemade paste. Internal supplements lack a comparably standardized, well-studied adult dose in the way willow’s salicin trials do.